Table 2 Clinical/surgical evaluation and diagnostic delay in study participants
From: Diagnostic delay and health-related quality of life in Egyptian women with endometriosis
Endometriosis (N = 70) | Controls (N = 57) | P value | |
|---|---|---|---|
Intensity of pelvic pain (NAS) | |||
Dysmenorrhea | 7.0 (0.0–9.0) | 0.0 (0.0–5.0) | 0.001 |
Dyspareunia | 2.0 (0.0–6.5) | 0.0 (0.0–5.0) | 0.214 |
Non-cyclic pain | 0.0 (0.0–6.0) | 0.0 (0.0–6.0) | 0.312 |
Endometriosis stage: (N, percent) | |||
Stages I/II endometriosis | 39 (56%) | N/A | |
Stages III/IV endometriosis | 31 (44%) | N/A | |
Diagnostic delay: (months since start of symptoms) | |||
Diagnostic delay (in months; median and IQR) | 36 (22.5–60) | 48 (24–84) | 0.080 |